SeekIn Inc, mutungamiri wekenza yeropa-yakatarisana nekutanga kuona uye yekutarisa tekinoroji, nhasi yazivisa CE (Conformité Européenne) Mark yeSeekInCare® Cancer Detection Kit uye yagadzirira kuita bvunzo iyi mumisika yeEurope.
Vanhu vanosvika mamiriyoni gumi vakafa negomarara gore rapfuura pasi rose. Ruzhinji rwegomarara rinowanikwa kunonoka kurapwa. Kuongororwa kenza kwegomarara kwekutanga kunogona kuponesa hupenyu, asi kungovhara mhando shoma dzegomarara dzakadai semapapu, colon, chiropa, zamu, cervix uye prostate zvine mwero wekutapukira uye hunhu. Muedzo mumwechete wekunyatsoongorora makomarara ese akaonekwa sechinangwa chekupedzisira chekuongorora gomarara kumunhu wese.
SeekIn ine yekugadzira njere-yakavakirwa papuratifomu inoshandisa nzwisiso kubva kune yakavanzika uye yeruzhinji data kuona isina kusimba gomarara DNA uye masaini eprotein muropa uye kuatsvaga achidzokera kune kwaakabva. SeekIn ine patents pane algorithms yekudzikisa ruzha rwekumashure uye kuratidza masaini egomarara muropa.
"Iri inhanho huru yechinangwa chedu chekuunza kuvhenekwa kwegomarara kubva muropa mukutonga kwegomarara," Mao Mao, MD, Ph.D., muvambi weSeekIn uye CEO, vakadaro mukutaura. "Gomarara chikamu chemhuri yangu uye ndanga ndichizvitsaurira kukudziridza tekinoroji yekuongorora kenza yeropa kubva muna 2014. epigenetic maitiro egomarara muropa, anomiririra imwe yehutatu hukuru hunyanzvi hwekuvheneka mhando dzegomarara dzakawanda uchishandisa chubhu yeropa. Kusanganiswa neakajairwa mapuroteni mamaki, bvunzo iyi ichakwanisa kuona akawanda emhando dzegomarara mune asymptomatic varwere apo gomarara rinogona kurapika. Kumaka kweEC kunomiririra chiitiko chakakosha cheSeekIn mukuunza SeekInCare bvunzo kune varwere nevarapi vehutano muEurope. Tichaenderera mberi nekuedza kwedu kuzadzisa zvimwe zvinodiwa muEurope, uye kuwana mvumo kune dzimwe nzvimbo dzakaita seChina neJapan. "
ZVOKUBVA MUNYAYA INO:
- Inspired by our clinical study in 2 million women, we took a unique approach to capture the common genomic and epigenetic features of cancer in blood, which represents one of the three major technologies to screen multiple cancer types using a tube of blood.
- SeekIn has an artificial intelligence-based platform that uses insights from both private and public data to identify weak cancer DNA and protein signals in the blood and trace them back to a tissue of origin.
- SeekIn Inc, mutungamiri wekenza yeropa-yakatarisana nekutanga kuona uye yekutarisa tekinoroji, nhasi yazivisa CE (Conformité Européenne) Mark yeSeekInCare® Cancer Detection Kit uye yagadzirira kuita bvunzo iyi mumisika yeEurope.
